Top intervention news of August: TAVR low-risk indications, FDA paclitaxel advisory and more

Healio compiled a list of the most-read cardiac and vascular intervention articles in August. This month, our readers were interested in the FDA approval of transcatheter aortic valve replacement devices for use in patients at low surgical risk, FDA recommendations on the signal of late mortality risk associated with paclitaxel-coated devices, the benefits of antiplatelet therapy in patients with atrial fibrillation who had TAVR and much more.

 

TAVR systems approved for low-risk patients

Edwards Lifesciences and Medtronic announced that their TAVR systems have been approved by the FDA for use in patients with severe symptomatic aortic stenosis at low surgical risk.

Read More

 

FDA advises clinicians to discuss risks of paclitaxel-coated devices with patients

The FDA issued a series of recommendations following an advisory panel meeting on a signal of late mortality risk associated with paclitaxel-coated devices to treat peripheral artery disease, including advising clinicians to discuss extensively with patients the risks and benefits of the devices and to ensure patients are on optimal medical therapy and are following appropriate lifestyle practices.

Read More

 

Antiplatelet therapy reduces stroke risk at 2 years in patients with AF undergoing TAVR

In patients with prior atrial fibrillation undergoing transcatheter aortic valve replacement, 6 months of uninterrupted antiplatelet therapy, with or without concomitant oral anticoagulation, was associated with a reduced risk for stroke at 2 years, whereas oral anticoagulation alone did not reduce risk in this population.

Read More

 

Operator experience not tied to outcomes after left atrial appendage occlusion

In a single-center study, there was no difference in outcomes after left atrial appendage occlusion according to operator volume.

Read More

 

AHA: ‘Thorough evaluation of limb perfusion’ critical in CLI

The American Heart Association released a scientific statement outlining the options for perfusion assessment in patients with critical limb ischemia.

Read More

 

BIO-RESORT: Three DES equal in TVF, stent thrombosis at 3 years

In the overall cohort of a randomized trial, three drug-eluting stents were associated with similar rates of target vessel failure and stent thrombosis at 3 years.

Read More

 

New catheter-based procedure adds option for PDA closure in newborns

Newborns with the congenital heart defect patent ductus arteriosus face many potential complications such as respiratory failure, acute kidney injury, necrotizing enterocolitis and HF. But closing it has been much easier said than done.

Read More

 

Post-PCI stroke more common in recent years

The incidence of ischemic stroke after PCI is low but has risen during the past decade, possibly due to an increase in patients with complex disease being treated with PCI, according to findings published in JACC Cardiovascular Interventions.

Read More

 

DCB catheter receives FDA breakthrough device designation

B. Braun Interventional Systems announced that a drug-coated balloon catheter for percutaneous transluminal coronary angioplasty has received a breakthrough device designation from the FDA for the treatment of patients with coronary in-stent restenosis.

Read More

 

Statin use promotes limb salvage, survival after PAD procedures

Among patients with peripheral artery disease who underwent a surgical or endovascular intervention, statin use after the procedure was associated with better odds of survival and limb salvage, researchers reported.

Read More

Healio compiled a list of the most-read cardiac and vascular intervention articles in August. This month, our readers were interested in the FDA approval of transcatheter aortic valve replacement devices for use in patients at low surgical risk, FDA recommendations on the signal of late mortality risk associated with paclitaxel-coated devices, the benefits of antiplatelet therapy in patients with atrial fibrillation who had TAVR and much more.

 

TAVR systems approved for low-risk patients

Edwards Lifesciences and Medtronic announced that their TAVR systems have been approved by the FDA for use in patients with severe symptomatic aortic stenosis at low surgical risk.

Read More

 

FDA advises clinicians to discuss risks of paclitaxel-coated devices with patients

The FDA issued a series of recommendations following an advisory panel meeting on a signal of late mortality risk associated with paclitaxel-coated devices to treat peripheral artery disease, including advising clinicians to discuss extensively with patients the risks and benefits of the devices and to ensure patients are on optimal medical therapy and are following appropriate lifestyle practices.

Read More

 

Antiplatelet therapy reduces stroke risk at 2 years in patients with AF undergoing TAVR

In patients with prior atrial fibrillation undergoing transcatheter aortic valve replacement, 6 months of uninterrupted antiplatelet therapy, with or without concomitant oral anticoagulation, was associated with a reduced risk for stroke at 2 years, whereas oral anticoagulation alone did not reduce risk in this population.

Read More

 

Operator experience not tied to outcomes after left atrial appendage occlusion

In a single-center study, there was no difference in outcomes after left atrial appendage occlusion according to operator volume.

Read More

 

AHA: ‘Thorough evaluation of limb perfusion’ critical in CLI

The American Heart Association released a scientific statement outlining the options for perfusion assessment in patients with critical limb ischemia.

Read More

 

BIO-RESORT: Three DES equal in TVF, stent thrombosis at 3 years

In the overall cohort of a randomized trial, three drug-eluting stents were associated with similar rates of target vessel failure and stent thrombosis at 3 years.

Read More

 

New catheter-based procedure adds option for PDA closure in newborns

Newborns with the congenital heart defect patent ductus arteriosus face many potential complications such as respiratory failure, acute kidney injury, necrotizing enterocolitis and HF. But closing it has been much easier said than done.

PAGE BREAK

Read More

 

Post-PCI stroke more common in recent years

The incidence of ischemic stroke after PCI is low but has risen during the past decade, possibly due to an increase in patients with complex disease being treated with PCI, according to findings published in JACC Cardiovascular Interventions.

Read More

 

DCB catheter receives FDA breakthrough device designation

B. Braun Interventional Systems announced that a drug-coated balloon catheter for percutaneous transluminal coronary angioplasty has received a breakthrough device designation from the FDA for the treatment of patients with coronary in-stent restenosis.

Read More

 

Statin use promotes limb salvage, survival after PAD procedures

Among patients with peripheral artery disease who underwent a surgical or endovascular intervention, statin use after the procedure was associated with better odds of survival and limb salvage, researchers reported.

Read More